CancerNCT02175823
Health Status Evaluation for Cancer Survivors by Non-intrusive Sensing System
An observational study of Cancer, run by National Taiwan University Hospital at 1 site in Taiwan.
Trial summary
To improve quality of life of elderly cancer survivors 1. Using physical activity and environmental sensing technology 2. Monitoring physiological indicators of cancer recurrence Analyzing the patient's circadian rhythm, frailty and his/her vital sign. Vital sign includes blood pressure, weight and hrv. 3. Read more about this study
- Who is it for?
- Ages 65 years and olderHealthy volunteers can take part
- Conditions the study is for
- Cancer
- How many people
- 40 participants
- Where
- 1 siteTaiwan
- Study dates
- Jul 2014to Jul 2015
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 65 years and older
- All sexes
- Healthy volunteers accepted
- Older adult
Study population: Elderly cancer survivors
Who may be able to join
- The clinical pathology and diagnostic imaging to determine the cancer who completed acute treatment, and patients with more than a month recuperating.
- Over 65 years old.
- Proficient in Chinese or Taiwanese.
- Normal cognitive function
Who cannot join
- No history of cancer
- Over 65 years old.
- Proficient in Chinese or Taiwanese.
- Normal cognitive function
Trial locations and contacts
1 site in 1 country.
Taiwan1 site
National Taiwan University Hospital
Taipei, Da'an Dist, 106
Li Chen Fu, +886-2-3366-3558, lichen@ntu.edu.tw
About this study
To improve quality of life of elderly cancer survivors
- Using physical activity and environmental sensing technology
- Monitoring physiological indicators of cancer recurrence
- Analyzing the patient's circadian rhythm, frailty and his/her vital sign.
- Vital sign includes blood pressure, weight and hrv.
- Collecting the patient information in real time
- Giving alarm information to the patient, if any special cases our system found.
- Giving circadian rhythm report to the patient.
- Giving healthy report to the patient, collected from his/her vital sign.
- Conditions
- Cancer
- Keywords
- Cancer survivors, circadian rhythm, Elderly Patients, frailty
- Medical subject headings
- Neoplasms, Frailty
What is being measured
The primary outcome is the main question the study is designed to answer.
Quality of Life
Measured: Three weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 Jun 2014 (estimated)
- Study startJul 2014
- Primary completionJul 2015 (estimated)
- Study completionJul 2015 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for CancerStudies of the same condition, open and under way.
- More trials run by National Taiwan University HospitalThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Ecologic or community
- Time perspective
- Prospective
- Enrolment
- 40 participants (estimated)
Sponsor and investigators
- Lead sponsor
- National Taiwan University Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Li Chen Fu, Principal investigator, Computer Science and Information Engineering
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02175823
- Sponsor's protocol ID
- 201401056RIND
- Status last verified
- Jul 2014
- First submitted
- 25 Jun 2014
- Last updated
- 8 Jul 2014
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 8 Jul 2014. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Health Status Evaluation for Cancer Survivors by Non-intrusive Sensing System
- ClinicalTrials.gov ID
- NCT02175823
- Acronym / sponsor ID
- 201401056RIND
- Conditions
- Cancer
- Keywords
- Cancer survivors, circadian rhythm, Elderly Patients, frailty
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 40 participants (estimated)
- Lead sponsor
- National Taiwan University HospitalUniversity, hospital or other
- Study start
- Jul 2014
- Primary completion
- Jul 2015 (estimated)
- Study completion
- Jul 2015 (estimated)
- First posted
- 26 Jun 2014 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
To improve quality of life of elderly cancer survivors
- Using physical activity and environmental sensing technology
- Monitoring physiological indicators of cancer recurrence
- Analyzing the patient's circadian rhythm, frailty and his/her vital sign.
- Vital sign includes blood pressure, weight and hrv.
- Collecting the patient information in real time
- Giving alarm information to the patient, if any special cases our system found.
- Giving circadian rhythm report to the patient.
- Giving healthy report to the patient, collected from his/her vital sign.
Study design
- Observational model
- Ecologic or community
- Time perspective
- Prospective
Who may qualify
- Ages
- 65 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Older adult
- Study population
- Elderly cancer survivors
Key inclusion criteria (4 listed)
- The clinical pathology and diagnostic imaging to determine the cancer who completed acute treatment, and patients with more than a month recuperating.
- Over 65 years old.
- Proficient in Chinese or Taiwanese.
- Normal cognitive function
Key exclusion criteria (4 listed)
- No history of cancer
- Over 65 years old.
- Proficient in Chinese or Taiwanese.
- Normal cognitive function
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Quality of Life
Time frame: Three weeks
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 Jul 2014.
Related trials for Cancer
Not yet recruitingPhase 1
Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy
Colorectal Neoplasms, Neoplasms
RecruitingPhase 2
Tafasitamab With Acalabrutinib and Venetoclax for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Active, not recruitingPhase 1/2
Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma
Low Grade Glioma, Recurrent Childhood Pilocytic Astrocytoma
Enrolling by invitationPhase 2
A Single-Arm Study of Nimotuzumab Combined With NALIRIFOX as First-Line Treatment for Pancreatic Cancer
Pancreatic Cancer Metastatic
Recruiting
Methylation Profiling in Self-Samples for Identification of (Epi)Genetic Biomarkers for Gynecological Cancers
Gynaecological Cancers, Ovarian Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Li Chen Fu principal investigator
Computer Science and Information Engineering
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Cancer, run by National Taiwan University Hospital at 1 site in Taiwan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 8 Jul 2014. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Li Chen Fu (+886-2-3366-3558, lichen@ntu.edu.tw), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Quality of Life (time frame: Three weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Jul 2014.